Radiopharm Theranostics Limited
RDPTF
$0.0113
$0.01051,312.50%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 20.90% | 19.06% | -3.71% | -1.15% | -86.88% |
| Total Depreciation and Amortization | -- | -- | -53.42% | -54.57% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -142.08% | -143.07% | -64.68% | -65.55% | 2,186.14% |
| Change in Net Operating Assets | -- | -- | 479.17% | 469.76% | -- |
| Cash from Operations | -88.68% | -93.10% | 1.01% | 3.46% | 3.08% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 35.96% | 35.96% | -- | -- | -- |
| Issuance of Common Stock | 2,068.74% | 2,068.74% | -- | -- | -79.02% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -5,356.70% | -5,356.70% | -10,101.11% | -10,101.11% | 83.94% |
| Cash from Financing | 1,749.29% | 1,792.72% | 146,004.76% | 143,431.25% | -78.76% |
| Foreign Exchange rate Adjustments | 4,144.74% | 4,260.53% | -113.97% | -113.66% | -108.24% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 282.15% | 286.40% | 231.16% | 227.92% | -255.47% |
